One company has introduced a new silicone-adhesive hydrocellular foam dressing with improvements for wound management and pressure reduction. In vitro data, comparing the pressure reducing ability of various dressings, identified improved mean pressure reduction with the new foam, compared to that of traditional silicone foam dressings.
A pre-market evaluation of the new foam dressing was conducted, as part of a comprehensive plan to reduce sacral/coccyx pressure ulcers in a 24-bed med/surg/neuro ICU. Average Braden Scale score was 12.3.
The 22 forms revealed ease of application as excellent (86%) or very good (14%); ease of removal: excellent (72%) or very good (28%); conformability: excellent (45%) or very good (55%); ability to remain adhered without rolling: excellent (82%), very good (12%) or good (6%); and ease of re-application after skin inspection: excellent (83%) or very good (17%).
The average dressing wear time was 4 days. Patient’s skin remained intact for all patients, dressing was applied on two patients with prior skin conditions; a Stage I and IAD Lesion, both resolved.